CureAccelerator Live!, Current Research, Dr. Gordon, Drug, Minority/Underserved, Oncology, Pediatric, Rare, The University of Texas MD Anderson Cancer Center
Enhancing Treatment Response in Recurrent/Metastatic Osteosarcoma with Hydroxychloroquine Principal Investigator: Dr. Nancy Gordon Disease: Osteosarcoma Research Description: Osteosarcoma (OS) is an orphan disease affecting approximately 400 children and adolescents...
Adult, Chicago, CureAccelerator Live!, Current Research, Drug, Loyola University Medical Center, Oncology, Rare
Repurposing the Blood Pressure Drug Minoxidil for the Treatment of Recurrent Chemo-Resistant Ovarian Cancer Principal Investigator: Dr. Margaret Liotta Disease: Ovarian cancer Research Description: Epithelial ovarian cancer is the most lethal among the gynecological...
Combo, Current Research, Drug, Oncology, Pre-clinical, Prof. Allen, Rare, University of Cambridge
Testing two generic drugs to improve outcomes in osteosarcoma, a rare bone cancer Principal Investigator: Prof. Matthew Allen Disease: Osteosarcoma Research Description: Although osteosarcoma (OSA) is a rare type of cancer, it is the most common bone cancer in...
Adult, CureAccelerator Live!, Current Research, Dr. Phillips, Drug, Minority/Underserved, Oncology, Rare, University of Michigan
Improving Patient Response in Mantle Cell Lymphoma with Venetoclax Principal Investigator: Dr. Tycel Phillips Disease: Mantle cell lymphoma Research Description: Mantle cell lymphoma (MCL) is a rare form of non-Hodgkin lymphoma (NHL) that is diagnosed mostly in older...
Children's Hospital of Philadelphia, Current Research, Diagnostic, Dr. Seif, Drug, Mid-Atlantic, Oncology, Pediatric, Rare
Preventing Relapse After Bone Marrow Transplant in Pediatric Acute Lymphoblastic Leukemia (ALL) with a Personalized Treatment Principal Investigator: Dr. Alix Seif Disease: Acute Lymphoblastic Leukemia Research Description: Pediatric acute lymphoblastic leukemia (ALL)...
Adult, CureAccelerator Live!, Current Research, Dr. Fleischman, Drug, Oncology, Rare, University of California Irvine
Treating a Group of Rare Blood Cancers, Myeloproliferative Neoplasms, with N-Acetylcysteine Principal Investigator: Dr. Angela Fleischman Disease: Myeloproliferative neoplasms: Polycythemia vera, essential thrombocythemia and myelofibrosis Research Description:...
